Suchergebnisse - "Ikeda, Shunya"

PubPharm (227)

101

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan

enthalten in: Journal of gastroenterology | 2019

von Kobayashi, M. | Kudo, M. | Izumi, N. | +7

102

Serum selenium levels in tuberculosis patients : A systematic review and meta-analysis

enthalten in: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) | 2018

von Muzembo, B. | Mbendi, N. | Ngatu, N. | +3

103

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

enthalten in: Journal of pharmaceutical health care and sciences | 2018

von Shimizu, H. | Suzuki, K. | Uchikura, T. | +12

104

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

enthalten in: Journal of pharmaceutical health care and sciences | 2018

von Shimizu, H. | Suzuki, K. | Uchikura, T. | +12

105

Mirabegron or tolterodine for the treatment of overactive bladder in Japan : Which drug is more cost-effective as the first-line treatment?

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2018

von Yamanishi, Y. | Yamanishi, T. | Tajima, H. | +1

106

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

enthalten in: Journal of pharmaceutical health care and sciences | 2018

von Shimizu, H. | Suzuki, K. | Uchikura, T. | +12

107

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2017

von Feng, Y. | Herdman, M. | van Nooten, F. | +5

108

New decision-making processes for the pricing of health technologies in Japan : The FY 2016/2017 pilot phase for the introduction of economic evaluations

enthalten in: Health policy (Amsterdam, Netherlands) | 2017

von Shiroiwa, T. | Fukuda, T. | Ikeda, S. | +1

109

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D

enthalten in: Quality of life research | 2017

von Feng, Y. | Herdman, M. | van Nooten, F. | +5

110

Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2017

von Shiroiwa, T. | Fukuda, T. | Ikeda, S. | +2